(1)
Shanehsaz, S. M.; Ishkhanian, S. Electrocardiographic and Biochemical Adverse Effects of Meglumine Antimoniate (MA) During Treatment of Syrian Cutaneous Leishmaniasis Patients. J Pak Assoc Dermatol 2016, 23, 412-417.